lobbying_activities: 2591564
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2591564 | eb35a7e7-3688-4db1-8b74-18f836e21657 | Q1 | CRANE STRATEGIES | 400927689 | REGENERON PHARMACEUTICALS, INC. | 2021 | first_quarter | BUD | Coronavirus therapeutic funding | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-02T10:34:32.237000-04:00 |